Understanding complexity in neurodegenerative diseases: In silico reconstruction of emergence

Frontiers in Physiology

Volumn 3 JUL, Issue , 2012, Pages

  Kolodkin, Alexey ^a,b   Simeonidis, Evangelos ^a,b   Balling, Rudi ^a   Westerhoff, Hans V ^c,d,e  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Computer modeling; Network diseases; Neurodegenerative disease; Parkinson's disease (PD); Strong emergence; Systems biology; Systems biology diseases; Weak emergence

Indexed keywords

EID: 84866527808     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00291     Document Type: Article

References (69)

1. Andrews, S. S., Addy, N. J., Brent, R., and Arkin, A. P. (2010). Detailed simulations of cell biology with Smoldyn 2.1. PLoS Comput. Biol. 6:e1000705. doi: 10.1371/journal.pcbi.1000705
2. Aouabdi, S., Gibson, G., and Plant, N. (2006). Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab. Dispos. 34, 138-144.
3. Bakker, B. M., Assmus, H. E., Bruggeman, F., Haanstra, J. R., Klipp, E., and Westerhoff, H. (2002). Network-based selectivity of antiparasitic inhibitors. Mol. Biol. Rep. 29, 1-5.
4. Bakker, B. M., Mensonides, F. I., Teusink, B., Van Hoek, P., Michels, P. A., and Westerhoff, H. V. (2000). Compartmentation protects try-panosomes from the dangerous design of glycolysis. Proc. Natl. Acad. Sci. U.S.A. 97, 2087-2092.
5. Bakker, B. M., Michels, P. A., Opperdoes, F. R., and Westerhoff, H. V. (1997). Glycolysis in bloodstream form trypanosoma brucei can be understood in terms of the kinetics of the glycolytic enzymes. J. Biol. Chem. 272, 3207-3215.
6. Bakker, B. M., Michels, P. A., Opperdoes, F. R., and Westerhoff, H. V. (1999). What controls glycolysis in bloodstream form Trypanosoma brucei? J. Biol. Chem. 274, 14551-14559.
7. Boogerd, F. C., Bruggeman, F., Hofmeyr, J. H. S., and Westerhoff, H. V. (2007). Systems Biology Philosophical Foundations. Amsterdam: Elsevier.
8. Boogerd, F. C., Bruggeman, F. J., Richardson, R. C., Stephan, A., and Westerhoff, H. V. (2005). Emergence and its place in nature: a case study of biochemical networks. Synthese 145, 131-164.
9. Boogerd, F. C., Ma, H. W., Bruggeman, F. J., Van Heeswijk, W. C., Garcia-Contreras, R., Molenaar, D., Krab, K., and Westerhoff, H. V. (2011). AmtB-mediated NH3 transport in prokaryotes must be active and as a consequence regulation of transport by GlnK is mandatory to limit futile cycling of NH4+/NH3. FEBS Lett. 585, 23-28.
10. Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehar, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., and Keith, C. T. (2003). Systematic discovery of multicomponent therapeutics. Proc. Natl. Acad. Sci. U.S.A. 100, 7977-7982.
11. Brady, N. R., Elmore, S. P., Van Beek, J. J., Krab, K., Courtoy, P. J., Hue, L., and Westerhoff, H. V. (2004). Coordinated behavior of mitochondria in both space and time: a reactive oxygen species-activated wave of mitochondrial depolarization. Biophys. J. 87, 2022-2034.
12. Broad, C. D. (1925). The Mind and Its Place in Nature. London: Kegan Paul, Trench, Trubner and Co.
13. Bruggeman, F. J., Bluthgen, N., and Westerhoff, H. V. (2009). Noise management by molecular networks. PLoS Com-put. Biol. 5:e1000506. doi: 10.1371/journal.pcbi.1000506
14. Bruggeman, F. J., and Westerhoff, H. V. (2006). Approaches to biosimu-lation of cellular processes. J. Biol. Phys. 32, 273-288.
15. Carlberg, C., and Dunlop, T. W. (2006). An integrated biological approach to nuclear receptor signaling in physiological control and disease. Crit. Rev. Eukaryot. Gene Expr. 16, 1-22.
16. Choi, D. H., Cristovao, A. C., Guhathakurta, S., Joh, T., Beal, F., and Kim, Y. S. (2011). NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid. Redox Signal. 16, 1033-1045.
17. Cui, T., Fan, C., Gu, L., Gao, H., Liu, Q., Zhang, T., Qi, Z., Zhao, C., Zhao, H., Cai, Q., and Yang, H. (2011). Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminer-gic MN9D cells. Brain Res. 1394, 1-13.
18. Cutress, M. L., Whitaker, H. C., Mills, I. G., Stewart, M., and Neal, D. E. (2008). Structural basis for the nuclear import of the human androgen receptor. J. Cell. Sci. 121, 957-968.
19. Del Sol, A., Balling, R., Hood, L., and Galas, D. (2010). Diseases as network perturbations. Curr. Opin. Biotechnol. 21, 566-571.
20. Ebert, R., Schutze, N., Adamski, J., and Jakob, F. (2006). Vitamin D signaling is modulated on multiple levels in health and disease. Mol. Cell. Endocrinol. 248, 149-159.
21. Einstein, A. (1961). Relativity. New York, NY: Crown Publishers.
22. El-Sankary, W., Bombail, V., Gibson, G. G., and Plant, N. (2002). Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab. Dispos. 30, 1029-1034.
23. El-Sankary, W., Gibson, G. G., Ayrton, A., and Plant, N. (2001). Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers. Drug Metab. Dispos. 29, 1499-1504.
24. Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., and Keshavarzian, A. (2011). Increased intestinal permeability correlates with sig-moid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS ONE 6:e28032. doi: 10.1371/journal.pone.0028032
25. Gardner, R. S. (1975). Nuclear thyroid-hormone receptors - evidence for association with nucleolar chromatin. Biochem. Biophys. Res. Commun. 67, 625-633.
26. Glansdorff, P., Nicolis, G., and Prigogine, I. (1974). The ther-modynamic stability theory of non-equilibrium states. Proc. Natl. Acad. Sci. U.S.A. 71, 197-199.
27. Groen, A. K., Wanders, R. J., Westerhoff, H. V., Van Der Meer, R., and Tager, J. M. (1982). Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 257, 2754-2757.
28. Haanstra, J. R., Van Tuijl, A., Kessler, P., Reijnders, W., Michels, P. A., Westerhoff, H. V., Parsons, M., and Bakker, B. M. (2008). Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes. Proc. Natl. Acad. Sci. U.S.A. 105, 17718-17723.
29. Herrgård, M. J., Swainston, N., Dobson, P., Dunn, W. B., Arga, K. Y., Arvas, M., Blüthgen, N., Borger, S., Costenoble, R., Heinemann, M., Hucka, M., Le Novère, N., Li, P., Liebermeister, W., Mo, M. L., Oliveira, A. P., Petranovic, D., Pettifer, S., Simeonidis, E., Smallbone, K., Spasić, I., Weichart, D., Brent, R., Broomhead, D. S., Westerhoff, H. V., Kirdar, B., Penttilä, M., Klipp, E., Palsson, B. Ø., Sauer, U., Oliver, S. G., Mendes, P., Nielsen, J., and Kell, D. B. (2008). A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat. Biotechnol. 26, 1155-1160.
30. Hornberg, J. J., Binder, B., Bruggeman, F. J., Schoeberl, B., Heinrich, R., and Westerhoff, H. V. (2005). Control of MAPK signalling: from complexity to what really matters. Oncogene 24, 5533-5542.
31. Hornberg, J. J., Bruggeman, F. J., Westerhoff, H. V., and Lankelma, J. (2006). Cancer: a systems biology disease. Biosystems 83, 81-90.
32. Hunter, P., Kurachi, Y., Noble, D., and Viceconti, M. (2008). Meeting report on the 2nd MEI international symposium - the worldwide challenge to physiome and systems biology and osaka accord. J. Physiol. Sci. 58, 425-431.
33. Kacser, H., and Burns, J. A. (1973). The control of flux. Symp. Soc. Exp. Biol. 27, 65-104.
34. Kartal, O., Mahlow, S., Skupin, A., and Ebenhoh, O. (2011). Carbohydrate-active enzymes exemplify entropic principles in metabolism. Mol. Syst. Biol. 7, 542.
35. Kestler, H. A., Wawra, C., Kracher, B., and Kuhl, M. (2008). Network modeling of signal transduction: establishing the global view. Bioessays 30, 1110-1125.
36. Kolodkin, A., Boogerd, F. C., Plant, N., Bruggeman, F. J., Goncharuk, V., Lunshof, J., Moreno-Sanchez, R., Yilmaz, N., Bakker, B. M., Snoep, J. L., Balling, R., and Westerhoff, H. V. (2011a). Emergence of the silicon human and network targeting drugs. Eur. J. Pharm. Sci. 46, 190-197.
37. Kolodkin, A. N., Boogerd, F. C., Bruggeman, F. J., and Westerhoff, H. V. (2011b). " Modeling approaches in systems biology, including silicon cell models," in Systems Biology and Livestock Science, eds T. M. F. W. Pas, H. Woelders, and A. Bannink (Oxford, UK: Wiley-Blackwell), 31-53.
38. Kolodkin, A. N., Bruggeman, F. J., Plant, N., Mone, M. J., Bakker, B. M., Campbell, M. J., Van Leeuwen, J. P., Carlberg, C., Snoep, J. L., and Westerhoff, H. V. (2010). Design principles of nuclear receptor signaling: how complex networking improves signal transduction. Mol. Syst. Biol. 6, 446.
39. Kolodkin, A. N., and Westerhoff, H. V. (2011). Parsimony for Systems Biology: shaving Occam's Razor away. Eur. Commun. Math. Theor. Biol. 14, 149-152.
40. Lauffenburger, D. A. (2000). Cell signaling pathways as control modules: complexity for simplicity? Proc. Natl. Acad. Sci. U.S.A. 97, 5031-5033.
41. Lee, S. J., Lim, H. S., Masliah, E., and Lee, H. J. (2011). Protein aggregate spreading in neurode-generative diseases: problems and perspectives. Neurosci. Res. 70, 339-348.
42. Lehar, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short, G. F. 3rd., Staunton, J. E., Jin, X., Lee, M. S., Zimmermann, G. R., and Borisy, A A. (2009). Synergistic drug com binations tend to improve thera- peutically relevant selectivity. Nat. Biotechnol. 27, 659-666.
43. Lehrach, H., Subrak, R., Boyle, P., Pasterk, M., Zatloukal, K., Müller, H., Hubbard, T., Brand, A., Girolami, M., Jameson, D., Bruggeman, F. J., and Westerhoff, H. V. (2011). ITFoM - the IT future of medicine. Procedia Comput. Sci. 7, 26-29.
44. Luni, C., Shoemaker, J. E., Sanft, K. R., Petzold, L. R., and Doyle, F. J. 3rd. (2010). Confidence from uncertainty-a multi-target drug screening method from robust control theory. BMC Syst. Biol. 4, 161.
45. Mccoy, M. K., and Cookson, M. R. (2011). Mitochondrial quality control and dynamics in Parkinson's disease. Antioxid. Redox Signal. 16, 669-682.
46. Mitchell, P. (1961). Coupling of phos-phorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191, 144-148.
47. Murta, A. (2012). Occam's razor-essentials and applications, published on http://albertomurta. wikispaces.com/file/view/Occam's+ razor+review.pdf.
48. Noble, D. (2006). The Music of Life: Biology Beyond Genes. Oxford, UK: Oxford University Press.
49. Phillips, A. L., Hood, S. R., Gibson, G. G., and Plant, N. J. (2003). CYP3A and nuclear receptor messenger RNA expression in liver and HuH7 cells. Drug Metab. Rev. 35, 83.
50. Reijenga, K. A., Van Megen, Y., Kooi, B W., Bakker, B. M., Snoep, J. L., Van Verseveld, H. W., and Westerhoff, H. V. (2005). Yeas glycolytic oscillations that are no controlled by a single oscillophore a new definition of oscillophor strength. J. Theor. Biol. 232 385-398.
51. Renz, H., Von Mutius, E., Brandtzaeg P., Cookson, W. O., Autenrieth I. B., and Haller, D. (2011) Gene-environment interactions i chronic inflammatory disease. Nat Immunol. 12, 273-277.
52. Rohwer, J. M., Meadow, N. D. Roseman, S., Westerhoff, H V., and Postma, P. W. (2000) Understanding glucose transpor by the bacterial phosphoenolpyru vate:glycose phosphotransferas system on the basis of kineti measurements in vitro. J. Biol Chem. 275, 34909-34921.
53. Selivanov, V. A., Votyakova, T V., Pivtoraiko, V. N., Zeak, J. Sukhomlin, T., Trucco, M., Roca J., and Cascante, M. (2011) Reactive oxygen species pro duction by forward and revers electron fluxes in the mitochon drial respiratory chain. PLo Comput. Biol. 7:e1001115. doi 10.1371/journal.pcbi.1001115
54. Snoep, J. L., Bruggeman, F., Olivier, B G., and Westerhoff, H. V. (2006) Towards building the silicon cell: modular approach. Biosystems 83 207-216.
55. Stephan, A. (2006). The dual rol of 'emergence' in the philosoph of mind and in cognitive science Synthese 151, 485-498.
56. Teusink, B., Passarge, J., Reijenga C. A., Esgalhado, E., Van De Weijden, C. C., Schepper, M. Walsh, M. C., Bakker, B. M. Van Dam, K., Westerhoff, H V., and Snoep, J. L. (2000). Ca yeast glycolysis be understoo in terms of in vitro kinetics o the constituent enzymes? testin biochemistry. Eur. J. Biochem. 267 5313-5329.
57. Teusink, B., Walsh, M. C., Van Dam, K., and Westerhoff, H. V. (1998). The danger of metabolic pathways with turbo design. Trends Biochem. Sci. 23, 162-169.
58. Tian, Q., Price, N. D., and Hood, L. (2012). Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J. Intern. Med. 271, 111-121.
59. Tiraboschi, P., Hansen, L. A., Thal, L. J., and Corey-Bloom, J. (2004). The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62, 1984-1989.
60. Verlinde, E. (2011). On the origin of gravity and the laws of Newton. J. High Energy Phys. 2011, 1-27.
61. Volpe, M., Chin, D., and Paneni, F. (2010). The challenge of polyphar-macy in cardiovascular medicine. Fundam. Clin. Pharmacol. 24, 9-17.
62. Wall, M. E., Hlavacek, W. S., and Savageau, M. A. (2004). Design of gene circuits: lessons from bacteria. Nat. Rev. Genet. 5, 34-42.
63. Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., Selkoe, D., Rice, S., Steen, J., Lavoie, M. J., and Schwarz, T. L. (2011). PINK1 and parkin target miro for phospho-rylation and degradation to arrest mitochondrial motility. Cell 147, 893-906.
64. Westerhoff, H. V. (2001). The silicon cell, not dead but live! Metab. Eng. 3, 207-210.
65. Westerhoff, H. V., and Chen, Y. D. (1984). How do enzyme-activities control metabolite concentrations-an additional theorem in the theory of metabolic control. Eur. J. Biochem. 142, 425-430.
66. Westerhoff, H. V., Kolodkin, A., Conradie, R., Wilkinson, S. J., Bruggeman, F. J., Krab, K., Van Schuppen, J. H., Hardin, H., Bakker, B. M., Mone, M. J., Rybakova, K. N., Eijken, M., Van Leeuwen, H. J., and Snoep, J. L. (2009a). Systems biology towards life in silico: mathematics of the control of living cells. J. Math. Biol. 58, 7-34.
67. Westerhoff, H. V., and Van Dam, K. (1987). Thermodynamics and Control of Biological Free Energy Tr a n s d u c t i o n. Amsterdam: Elsevier.
68. Westerhoff, H. V., Winder, C., Messiha, H., Simeonidis, E., Adamczyk, M., Verma, M., Bruggeman, F. J., and Dunn, W. (2009b). Systems biology: the elements and principles of life. FEBS Lett. 583, 3882-3890.
69. Wouters, A. G. (2007). Design explanation: determining the constraints on what can be alive. Erkenntnis 67, 65-80